Abstract
Background
Lehigh Valley Health Network (LVHN), a nonprofit tertiary care facility in Allentown, Pennsylvania, is an accredited American College of Surgeons Bariatric Surgery Center Network (ACSBSCN) Level 1 site performing 400+ bariatric procedures annually. Bariatric data submission began in April 2008. Complication review revealed that approximately 17 % of patients on chronic anticoagulation (warfarin) therapy preoperatively were readmitted with supratherapeutic international normalized ratios (INRs), postsurgical bleeding, anastomotic ulcer, or other intraluminal hemorrhage. Opinion level recommendations have been published regarding the adjustment of warfarin dosages post-bariatric procedures with no widespread consensus. Case series have been published detailing perioperative hemorrhage risk for bariatric patients on preoperative anticoagulation. Little data of post-discharge hemorrhage rates have been published. With increasing numbers of bariatric surgical procedures performed annually, there is a potential for developing serious coagulopathic complications in those patients who resume their anticoagulation therapy postoperatively.
Methods
Retrospective review of LVHN data from the ACSBSCN database was analyzed for 30-day readmissions due to documented extra- or intraluminal hemorrhage with INR and coagulopathy. Follow-up INR and warfarin doses were collected up to 6 months postoperatively.
Results
Over a 3-year period, 38 patients undergoing bariatric procedures were identified as being on preoperative warfarin therapy. Six of 38 developed hemorrhage within 30 days. Two patients presented beyond 30 days with bleeding. Supratherapeutic INR was present in five of six readmitted patients. Mean INR was 5.8. Warfarin sensitivity was present in a statistically significant higher number of patients within 30 days of surgery. After 30 days, a resistance to warfarin was demonstrated.
Conclusions
Bariatric surgery patients taking warfarin are prone to coagulopathy in the early post-op period requiring vigilant monitoring to prevent supratherapeutic INR and corresponding risk of hemorrhage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
US Dept Health & Human Services. Blood thinner pills: your guide to using them safely. AHRQ Publication no. 09-0086-C. 2010. Rockville.
Mehran A, Szomstein S, Zundel N, et al. Management of acute bleeding after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(6):842–7.
Al Harakeh AB. Complications of laparoscopic Roux-en-Y gastric bypass. Surg Clin North Am. 2011;91(6):1225–37. viii.
Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg. 2003;138(9):957–61.
Finks JF, Carlin A, Share D, et al. Effect of surgical techniques on clinical outcomes after laparoscopic gastric bypass—results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis. 2011;7(3):284–9.
Mourelo R, Kaidar-Person O, Fajnwaks P, et al. Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. Obes Surg. 2008;18(2):167–70.
Lincoln EVV, Ferreira LE, Song LM, et al. Management of acute postoperative hemorrhage in the bariatric patient. Gastrointest Endosc Clin N Am. 2011;21(2):287–94.
Pannucci CJ, Wachtman CF, Dreszer G, et al. The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg. 2012;129(1):160–8.
Ojo P, Asiyanbola B, Valin E, et al. Post discharge prophylactic anticoagulation in gastric bypass patient-how safe? Obes Surg. 2008;18(7):791–6.
Rabl C, Peeva S, Prado K, et al. Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg. 2011;21(4):413–20.
Van Mieghem T, Van Schoubroeck D, Depiere M, et al. Fetal cerebral hemorrhage caused by vitamin K deficiency after complicated bariatric surgery. Obstet Gynecol. 2008;112(2 Pt 2):434–6.
Eerdekens A, Debeer A, Van Hoey G, et al. Maternal bariatric surgery: adverse outcomes in neonates. Eur J Pediatr. 2010;169(2):191–6.
Smith A, Henriksen B, Cohen A, et al. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm. 2011;68(23):2241–7.
Sease J. Can bariatric surgery affect warfarin management? 2010. http://www.medscape.com/index/list_6949_1. Accessed Mar 2012.
Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55.
Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm. 2006;63(19):1852–7.
Sobieraj DM, Wang F, Kirton OC. Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy. Pharmacotherapy. 2008;28(12):1537–41.
Bakhos C, Alkhoury F, Kyriakides T, et al. Early postoperative hemorrhage after open and laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2009;19(2):153–7.
Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg. 2004;240(2):243–7.
Turner PL, Saager L, Dalton J, et al. A nomogram for predicting surgical complications in bariatric surgery patients. Obes Surg. 2011;21:655–62.
Acknowledgments
The authors wish to acknowledge Cathy Webber, Cathy Fuhrman, and Amanda Curry for their roles in data collection and database management.
Conflict of Interest
The authors report no conflicts of interest and make no disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bechtel, P., Boorse, R., Rovito, P. et al. Warfarin Users Prone to Coagulopathy in First 30 Days After Hospital Discharge from Gastric Bypass. OBES SURG 23, 1515–1519 (2013). https://doi.org/10.1007/s11695-013-0972-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-0972-5